Cafepharma Today

June 5 2025 - GLP-1 drugs may be linked to elevated risk of serious eye disease, study finds
GLP-1 drugs may be linked to elevated risk of serious eye disease, study finds
Bispecific cancer drugs, data caveats and funding alarms: 3 takeaways from ASCO
FDA’s Elsa AI is here, and the industry has questions
Merck gains U.S. patent office support in Keytruda dispute
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

Raptor Pharma Rises as FDA Starts Drug Review
PharmPro
Saturday, June 16, 2012 - 1:52pm
tags:
RP103, Raptor Pharmaceuticals, nephropathic cystinosis
Alembic settles patent dispute with Novartis
Business Standard, India
Saturday, June 16, 2012 - 1:46pm
tags:
Alembic Pharmaceuticals, Breckenridge, Novartis, Exelon, generics, patents, lawsuits
Human Genome Goes Full Monty
Motley Fool
Saturday, June 16, 2012 - 1:40pm
tags:
Human Genome Sciences, M&A
A Long Shot In The Lupus Market Gains Attention
Seeking Alpha
Saturday, June 16, 2012 - 1:39pm
tags:
lupus, Anthera, blisibimod
Don't Sell: Pfizer Can Handle Crisis
Seeking Alpha
Saturday, June 16, 2012 - 1:38pm
tags:
Pfizer
Keep Your Eye On Merck
Seeking Alpha
Saturday, June 16, 2012 - 1:38pm
tags:
Merck
U.S. District Court Rules Against Merck in NASONEX® (mometasone furoate monohydrate) Patent Lawsuit
Yahoo/BusinessWire
Saturday, June 16, 2012 - 1:37pm
tags:
Merck, Nasonex, patents, lawsuits
Johnson & Johnson Widens Scope With Zytiga
Motley Fool
Saturday, June 16, 2012 - 12:50pm
tags:
JNJ, Zytiga, prostate cancer
The Shuman Law Firm Announces the Filing of a Class Action Lawsuit Against ViroPharma, Inc.
Yahoo/BusinessWire
Saturday, June 16, 2012 - 12:49pm
tags:
ViroPharma, lawsuits
Questcor eyes new markets
Yahoo/Investor's Business Daily
Saturday, June 16, 2012 - 12:48pm
tags:
Questcor Pharmaceuticals
New Zealand approves Osiris stem cell therapy
Yahoo/AP
Saturday, June 16, 2012 - 12:47pm
tags:
Osiris Therapeutics, Prochymal, stem cells, graft vs host disease
7 Healthcare Stocks Near Highs Being Bought Up By Hedge Funds
Seeking Alpha
Saturday, June 16, 2012 - 12:46pm
tags:
Ardea Biosciences, Synta Pharmaceuticals, Akorn, Omeros, Santarus, Amylin, Ariad Pharmaceuticals
Will Celgene’s Top Institutional Shareholders BUY More After the Stock Buyback?
Wall Street Cheat Street
Saturday, June 16, 2012 - 12:44pm
tags:
Cellgene
Zalicus' Z160 Could Change The World's Pain Market
Seeking Alpha
Saturday, June 16, 2012 - 12:43pm
tags:
Zalicus, Z160, pain management
Will Investors Give Questcor Pharmaceuticals The Shot It Needs To Move Higher?
investors.com
Saturday, June 16, 2012 - 12:41pm
tags:
Questcor Pharmaceuticals
Big-Cap Health Care Winners
The Steet
Saturday, June 16, 2012 - 12:38pm
tags:
Alexion, Intuitive Surgical
Questcor rises on new Acthar marketing plans
Yahoo/AP
Saturday, June 16, 2012 - 12:26pm
tags:
Questcor, Acthar, lupus, rheumatoid arthritis
Third Time Lucky for Glaxo
Yahoo/Zacks
Saturday, June 16, 2012 - 12:24pm
tags:
MenHibrix, vaccinces, meningococcal disease
Valeant Pharma paying up to $426 mln for OraPharma
Marketwatch
Friday, June 15, 2012 - 12:32pm
tags:
Valeant Pharmaceuticals, OraPharma, M&A
Johnson & Johnson files for approval of prostate cancer pill Zytiga earlier in treatment
Yahoo/AP
Friday, June 15, 2012 - 12:30pm
tags:
Zytiga, prostate cancer, JNJ

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

Not One of Your Easy Crystals
In the Pipeline
The Continuing Crisis, Part XV: The Horrendous Trump Budget
In the Pipeline
Taurine Revisited
In the Pipeline
A New Route to Asthma Treatment - Through the Liver, of All Places
In the Pipeline
One Drug's Supply Chain, In Detail
In the Pipeline
A Reaction to Alzheimer's Fraud
In the Pipeline
Whoa Now: Cautionary Tales from Materials Science
In the Pipeline
Inside a Scientific Paper Mill
In the Pipeline
Autoimmune Disease, Transformed?
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.